Quarterly report pursuant to Section 13 or 15(d)

Revision of Prior Period Financial Statements (Tables)

v3.21.1
Revision of Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Restatement [Abstract]  
Summary of Restatement of Balance Sheet
The effect of the adjustments on the line items within the Company’s consolidated balance sheet as of December 31, 2020 is as follows:
 
    
December 31, 2020
 
    
As
previously
reported
    
Adjustment
    
As adjusted
 
Inventories
   $ 30,292      $ (4,841    $ 25,451  
Current Assets
     50,464        (4,841      45,623  
Total Assets
     357,974        (4,841      353,133  
Accrued and other current liabilities
     56,381        (1,328      55,053  
Current liabilities
     233,207        (1,328      231,879  
Total Liabilities
     307,132        (1,328      305,804  
Accumulated Deficit
     (720,629      (3,513      (724,142
Total Shareholders’ Equity
     50,842        (3,513      47,329  
Total Liabilities and Shareholders’ Equity
     357,974        (4,841      353,133  
Summary of Restatement of Statement of Equity
T
he effect of the adjustments on the line items within the Company’s interim condensed consolidated statements of shareholder’s equity for the three months ended March 31, 2021 is as follow
s:
 
    
March 31, 2021
 
    
As
previously
reported
    
Adjustment
    
As adjusted
 
Deficit accumulated – Balance January 1, 2021
   $ (720,629    $ (3,513    $ (724,142
Shareholders’ equity total – Balance January 1, 2021
     50,842        (3,513      47,329